Publication | Open Access
Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram
15
Citations
44
References
2022
Year
DSF/Cu and sorafenib can synergistically and effectively treat HCC by targeting HCSCs <i>in vitro</i> and <i>in vivo</i>. Our data provide a foundation for clinical translation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1